Search Results

Return to List
Results 61–80 of 97
Title Date
61.

Ovarian Reserve Testing

Number 618

ABSTRACT: The main goal of ovarian reserve testing is to identify those individuals who are at risk of decreased or diminished ovarian reserve, commonly known as DOR. Although ovarian reserve testing cannot predict the end of one’s reproductive years, results outside the range expected for a patie...

January 2015

PDF Format
62.

Pain Relief During Labor

Number 295

(Reaffirmed 2008, Replaces No. 231, February 2000)

ABSTRACT: Pain management should be provided whenever medically indicated. The American Society of Anesthesiologists (ASA) and the American College of Obstetricians and Gynecologists (ACOG) believe that women requesting epidural analgesia during labor should not be deprived of this service based o...

July 2004

PDF Format
63.

Perinatal Risks Associated With Assisted Reproductive Technology

Number 324

(Reaffirmed 2007)

ABSTRACT: Over the past two decades, the use of assisted reproductive technology (ART) has increased dramatically worldwide and has made pregnancy possible for many infertile couples. A growing body of evidence suggests an association between pregnancies resulting from ART and perinatal morbidity ...

November 2005

PDF Format
64.

Personalized Genomic Testing for Disease Risk

Number 527

(Reaffirmed 2014)

ABSTRACT: Advances in genetic technologies have led to the identification of hundreds of single nucleotide polymorphisms that are associated with a variety of complex diseases, including cancer, diabetes, cardiovascular disease, and Alzheimer disease. Although personalized genomic tests that provi...

June 2012

PDF Format
65.

Placenta Accreta

Number 529

(Reaffirmed 2014)

ABSTRACT: Placenta accreta is a potentially life-threatening obstetric condition that requires a multidisciplinary approach to management. The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate. Women at greatest risk of placenta accreta are tho...

July 2012

PDF Format
66.

Planned Home Birth

Number 476

(Reaffirmed 2013)

ABSTRACT: Although the Committee on Obstetric Practice believes that hospitals and birthing centers are the safest setting for birth, it respects the right of a woman to make a medically informed decision about delivery. Women inquiring about planned home birth should be informed of its risks and ...

February 2011

PDF Format
67.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT: Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish (Ashkenazi) descent. Previously, the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screeni...

October 2009

PDF Format
68.

Prenatal and Perinatal Human Immunodeficiency Virus Testing - Expanded Recommendations

Number 418

(Reaffirmed 2011, Replaces No. 304, November 2004)

ABSTRACT: Early identification and treatment of all pregnant women with human immunodeficiency virus (HIV) is the best way to prevent neonatal disease and improve the woman's health. Human immunodeficiency virus screening is recommended for all pregnant women after they are notified that they will...

September 2008

PDF Format
69.

Preparing for Clinical Emergencies in Obstetrics and Gynecology

Number 590

(Replaces Committee Opinion Number 487, April 2011)

ABSTRACT: Patient care emergencies may occur at any time in any setting, particularly the inpatient setting. It is important that obstetrician–gynecologists prepare themselves by assessing potential emergencies, establishing early warning systems, designating specialized first responders, conducti...

March 2014

PDF Format
70.

Preparing for Disasters: Perspectives on Women

Number 457

(Reaffirmed 2014)

ABSTRACT: Emergency plans that specifically address the needs of women, infants, and children during disasters are currently underdeveloped in the United States. Pregnant women, infants, and children are adversely affected by disasters resulting in an increased number of infants with intrauterine ...

June 2010

PDF Format
71.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Reaffirmed 2013, Replaces No. 279, December 2002)

ABSTRACT: In 2010, the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease. Although universal screening at 35–37 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strateg...

April 2011

PDF Format
72.

Professional Liability and Gynecology-Only Practice

Number 567

(Replaces No. 408, June 2008)

ABSTRACT: Fellows of the American College of Obstetricians and Gynecologists may choose to limit the scope of their practices to gynecology and, accordingly, may choose not to carry professional liability coverage for obstetrics. The American College of Obstetricians and Gynecologists considers ea...

July 2013

PDF Format
73.

Reproductive Health Care for Adolescents with Human Immunodeficiency Virus

Number 572

ABSTRACT: Adolescents make up an increasing percentage of the U.S. population with human immunodeficiency virus (HIV). Adolescent-focused care is critical to identify and reduce at-risk behavior, comorbidities, and partner transmission. Optimal medical and reproductive health care, both now and in...

September 2013

PDF Format
74.

Reproductive Health Care for Incarcerated Women and Adolescent Females

Number 535

ABSTRACT: Increasing numbers of women and adolescent females are incarcerated each year in the United States and they represent an increasing proportion of inmates in the U.S. correctional system. Incarcerated women and adolescent females often come from disadvantaged environments and have high ra...

August 2012

PDF Format
75.

Scheduled Cesarean Delivery and the Prevention of Vertical Transmission of HIV Infection

Number 234

(Reaffirmed 2010, Replaces No. 219, August 1999)

Prevention of transmission of the human immunodeficiency virus (HIV) from mother to fetus or newborn (vertical transmission) is a major goal in the care of pregnant women infected with HIV. An important advance in this regard was the demonstration that treatment of the mother with zidovudine (ZDV)...

May 2000

PDF Format
76.

Screening for Depression During and After Pregnancy

Number 453

(Reaffirmed 2012)

Abstract: Depression is very common during pregnancy and the postpartum period. At this time, there is insufficient evidence to support a firm recommendation for universal antepartum or postpartum screening. There are also insufficient data to recommend how often screening should be done. There ar...

February 2010

PDF Format
77.

Screening for Tay - Sachs Disease

Number 318

(Reaffirmed 2014, Replaces No. 162, November 1995)

ABSTRACT: Tay–Sachs disease (TSD) is a severe progressive neurologic disease that causes death in early childhood. Carrier screening should be offered before pregnancy to individuals and couples at high risk, including those of Ashkenazi Jewish, French–Canadian, or Cajun descent and those with a f...

October 2005

PDF Format
78.

Sex Selection

Number 360

(Reaffirmed 2011)

ABSTRACT: In this Committee Opinion, the American College of Obstetricians and Gynecologists' Committee on Ethics presents various ethical considerations and arguments relevant to both prefertilization and postfertilization techniques for sex selection. The principal medical indication for sex sel...

February 2007

PDF Format
79.

Smoking Cessation During Pregnancy

Number 471

(Reaffirmed 2013, Replaces No. 316, October 2005)

ABSTRACT: Smoking is the one of the most important modifiable causes of poor pregnancy outcomes in the United States, and is associated with maternal, fetal, and infant morbidity and mortality. The physical and psychologic addiction to cigarettes is powerful; however, the compassionate interventio...

November 2010

PDF Format
80.

Solutions for Surgical Preparation of the Vagina

Number 571

ABSTRACT: Currently, only povidone-iodine preparations are approved for vaginal surgical-site antisepsis. However, there are compelling reasons to consider chlorhexidine gluconate solutions for off-label use in surgical preparation of the vagina, especially in women with allergies to iodine. Altho...

September 2013

PDF Format